Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
01/09/2025
The 20-year Japanese government bond yield rose by 2 basis points to 2.620%.
Latest
2 m ago
Nobel laureate warns: Lack of regulation of stablecoins could lead to governments being forced to provide assistance.
2 m ago
Financial report outlook | Salesforce (CRM.US) Q2 revenue forecast exceeds $10.1 billion, AI business ARR breaks billion and becomes a new growth engine?
5 m ago
On September 1st, Sihuan Pharmaceutical announced on the Hong Kong Stock Exchange that in order to promote the deep application and industrialization of artificial intelligence technology (AI) in the research and development of medical aesthetics products, the Group has signed a framework agreement with Shenyuan Zhiyao Biological Technology (Beijing) Co., Ltd. (referred to as "Shenyuan Zhiyao"). The two parties will jointly establish an AI research and development company led by the Group to explore the development of new medical aesthetic products driven by AI. This move marks the Group's strategic layout in the "AI + medical aesthetics" innovation track entering a substantive stage.
5 m ago
The Fourth Ring Pharmaceutical and Shenyuan Natural Medicine jointly established an AI research and development company to explore the development of new medical and cosmetic products driven by AI.
6 m ago
Huaxin Cement successfully acquired a well-known listed company in Nigeria.
See all latest